P3 Health Partners Inc.

NASDAQ: PIII · Real-Time Price · USD
6.70
-0.24 (-3.48%)
At close: Aug 15, 2025, 3:57 PM
6.78
1.12%
After-hours: Aug 15, 2025, 04:10 PM EDT

P3 Health Partners Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
373.23M 370.69M 362.12M 379.16M 388.49M 346.86M 288.35M 329.09M 302.08M 258.2M 248.26M 269.45M 273.54M 490.6B 156.52M 151.42M 151.3M
Cost of Revenue
379M 768.77M n/a 365.17M 403.6M 389.31M 300.94M 324.05M 307.11M 291.18M 276.59M 267.45M 287.57M 668.07M 161.33M 150.38M 146.62M
Gross Profit
-5.78M -398.08M 362.12M 13.99M -15.11M -42.45M -12.59M 5.04M -5.03M -32.98M -28.33M 2.01M -14.03M 489.94B -4.81M 1.04M 4.67M
Operating Income
-38.09M -138.5M -106.99M -31.33M -43.83M -64.26M -33.82M -21.03M -48.82M -536.5M -60.01M -912.19M -52.17M 60.55M -28.12M -19.44M -12.99M
Interest Income
322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-43.17M -124.2M -106.45M -27.81M -47.53M -67.34M -36.88M -27.36M -52.16M -530.5M -65.33M -903.11M -60.79M -31.33B -34.17M -24.97M -24.65M
Net Income
-20.48M -58.62M -46.51M -12.02M -18.7M -25.46M -13.3M -9.82M -9.2M -94.03M -11.17M -154.35M -10.58M 76.09M -32.05M -29.46M -24.65M
Selling & General & Admin
25.18M 31.83M 27.35M 27.02M 27.72M 25.15M 33.72M 28.08M 38.64M 41.4M 38.98M 42.51M 39.46M 54.84B 20.92M 18.75M 15.33M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
7.13M 477.36M 441.76M 18.3M -1M 3.34M 190K -741K 312.25M 289.9M 269.29M 1.49M 286.25M 464.29B n/a n/a n/a
Operating Expenses
32.31M 509.19M 469.11M 45.32M 28.72M 21.81M 322.17M 350.12M 350.89M 331.3M 308.27M 330.19M 325.71M 519.13B 184.64M 170.86M 164.29M
Interest Expense
8.72M 6.83M 5.65M 5.44M 4.26M 4.05M 4M 3.85M 4.09M 3.16M 2.96M 2.7M 2.76M 3.65M 2.53M 2.37M 2.12M
Selling & Marketing Expenses
181K 461K 134K 414K 322K 721K 654K 857K 1M 1.7M 1.12M 1.41M 864.53K 1.5B 491.42K 356.5K 270.24K
Cost & Expenses
411.31M 509.19M 469.11M 410.49M 432.32M 411.12M 322.17M 350.12M 350.89M 331.3M 308.27M 330.19M 325.71M 519.13B 184.64M 170.86M 164.29M
Income Tax Expense
1.07M 4.95M -3.6M 968K 2.07M 1.77M 412K 226K 290K 1.9M -51.41M -746.02M -47.45M -13.63M 3.93M 10.03M n/a
Shares Outstanding (Basic)
3.26M 3.25M 3.24M 2.73M 2.32M 2.31M 2.28M 2.15M 831.58K 831.58K 831.58K 831.58K 831.58K 831.58K 807.27K 807.27K 790.63K
Shares Outstanding (Diluted)
3.26M 3.25M 3.29M 2.82M 2.36M 2.31M 2.23M 2.15M 831.58K 831.58K 831.58K 831.58K 831.58K 831.58K 807.27K 807.27K 790.63K
EPS (Basic)
-6.28 -18.02 -14.37 -4.4 -8.08 -11.04 -5.82 -4.57 -11.06 -113.07 -13.44 -185.61 -12.72 -187.15 6.01 -13.04 6.09
EPS (Diluted)
-6.28 -20.82 -15.7 -7.37 -7.92 -11.04 -5.96 -0.09 -11.06 -113.07 -13.44 -186.55 -12.72 -187.15 6.01 -0.26 0.12
EBITDA
-13.4M -96.21M -79.14M -677K -21.74M -41.66M -11.15M -1.73M -26.53M -505.31M -40.76M -878.65M -36.28M -183.76M -27.67M -25.54M -12.66M
EBIT
-34.45M -117.36M -100.81M -22.37M -43.28M -63.29M -32.88M -23.5M -48.07M -527.31M -62.37M -900.41M -58.03M -192.48M -28.12M -27.09M -12.99M
Depreciation & Amortization
21.05M 21.15M 21.67M 21.69M 21.54M 21.63M 21.72M 21.78M 21.54M 22M 21.81M 21.72M 21.75M 8.72M 456.42K 429.83K 332.55K